News

As per the agreement, GP Pharm Mexico will be responsible for gaining regulatory approval in Mexico for Ampligen, an experimental therapeutic, to treat Chronic Fatigue Syndrome (CFS) in

Cambridge Research & Instrumentation develops and markets optical imaging systems to advance biomedical research and molecular-based drug and diagnostic development. CRi’s patented preclinical and tissue-based multiplexed analysis systems

The deal covers the installation, training and use of Sloning’s technology platform Slonomics for fabrication of highly-diverse gene and protein libraries at Pfizer’s subsidiary Rinat Neuroscience. Under the

iCare EMR integrates a simulated electronic medical record into a learning tool for students to prepare future nurses for the demands of the evolving healthcare climate in the

Sera Laboratories has launched liver microsome products from over 12 species, including mouse, rabbit, monkey and chicken, and the researchers can choose from pure microsomes or S9 fractions,

Ablynx said this is the first development candidate emerging from the strategic alliance which the companies entered into in 2007, and will result in a EUR5m milestone payment

Additional clinical endpoints, including reduction in disability progression, as measured by Expanded Disability Severity Scale (EDSS), were also achieved. In the trial, Laquinimod was safe and well-tolerated. In

V-Go devices will be available in a preset basal rate to deliver 20, 30 or 40 Units of insulin in one 24-hour period (0.83 U/hr, 1.25U/hr or 1.67U/hr

In November 2008, Zealand Pharma out-licensed ZP1846 to Helsinn Healthcare, under which Helsinn Healthcare received a worldwide exclusive license to ZP1846 and assumed responsibility for all further development,